Hwatsing Technology (SH:688120) 招商电子·2025-08-29 13:30Core Viewpoint - The company, Huahai Qingke, reported steady growth in revenue and profit for Q2 2025, maintaining high gross and net profit margins, with significant contributions from advanced process CMP equipment orders and successful progress in new product developments [1][2]. Financial Performance - In H1 2025, the company achieved revenue of 1.95 billion yuan, a year-on-year increase of 30.3%, and a net profit attributable to shareholders of 510 million yuan, up 16.8%. The growth in profit was slower than revenue due to rising employee compensation and the impact of the acquisition of Chipwave, alongside increased expense ratios and reduced interest income and government subsidies [1]. - For Q2 2025, revenue reached 1.04 billion yuan, representing a year-on-year increase of 27% and a quarter-on-quarter increase of 13.7%. The gross margin was 45.8%, up 0.9 percentage points year-on-year but down 0.5 percentage points quarter-on-quarter. The net profit attributable to shareholders was 270 million yuan, up 18% year-on-year and 16.5% quarter-on-quarter [1]. Product Development and Orders - The company saw a significant increase in orders for advanced process CMP equipment, with the new polishing system Universal-H300 receiving bulk repeat orders, achieving scale production. Advanced process CMP equipment orders accounted for a large proportion of new orders, with successful verification from several leading domestic clients [2]. - The self-developed 12-inch low-temperature ion implanter iPUMA-LT was delivered to a leading domestic logic chip fab, achieving full coverage of advanced process chip models. The company is also expanding its wafer regeneration capacity, with a planned total capacity of 400,000 pieces per month [2]. Investment Recommendations - The company is expected to maintain steady revenue growth and high profitability levels, with a significant proportion of new CMP equipment orders coming from advanced processes and substantial growth in orders for thinning machines. The progress of new products, including ion implanters, is also promising. Future revenue and net profit projections for 2025, 2026, and 2027 are anticipated to be strong, with corresponding PE ratios reflecting positive market sentiment [3].